The Diagman 2025 In Vitro Diagnostic Innovation Development and Upstream Solution Conference has successfully concluded

In May, the wise people of Gusu arrived. On May 28-29, 2025, the annual IVD industry event - Diagman In Vitro Diagnostic Innovation Development and Upstream Solution Conference and IVD Upstream Industry Chain Exhibition - successfully concluded at the Suzhou Shishan International Convention Center. This conference has gathered numerous industry elites to explore the cutting-edge technology and practical innovation of the IVD industry!

Diagmand2025

Deepening cooperation and gaining insights into new developments in the IVD field

The scene was crowded with people, including new and old friends from various industries, medical enterprises, and institutions, who came to gain a deeper understanding of product details, technological advantages, and cooperation models. WONGENY all-round innovative integrated solution has attracted widespread attention from many teachers in the industry. We conducted in-depth discussions on cutting-edge technologies, research and development strategies, and experiences in the industry, and highly recognized and expressed our intention to cooperate with WONGENY independent innovation and research and development capabilities.

On site keynote speeches and forums

Topic 1 of WONGENY Speech: Artificial Intelligence Empowers Technological Innovation in the Microfluidic Industry.

Topic 2 of WONGENY Speech: Platformization of Global Top Microfluidic Technology: Paradigm Shift from Single Point Breakthrough to Multi Domain Ecosystem Construction.

Topic 3 of WONGENY speech: The industrial dilemma of microfluidic chips: pseudo proposition or real bottleneck? Analyzing the Mass Production Curse of Product Commercialization.

This forum focuses on the dual main lines of "technology platform construction industrialization landing", using cutting-edge technology analysis, scenario based solutions, and industry university research practical cases as a three-dimensional perspective to deeply explore the development of microfluidic technology. WONGENY shared three core topics: AI empowering industry innovation, ecological paradigm shift of global technology platforms, and solutions to solve the dilemma of industrial mass production. The forum received an extremely enthusiastic response, attracting many industry colleagues to actively participate. The atmosphere on site was lively, and participants engaged in in-depth and productive exchanges around the shared content, exploring the innovative boundaries and future development directions of microfluidic technology with industry experts, effectively promoting ideological collision and cooperation opportunities.

100 ㎡ Intelligent Interactive CDMO Experience Center

Taking "from laboratory to mass production" as the main theme, the full lifecycle services of medical devices are dynamically presented through four core exhibition areas:

1. Research and development design area

Biochip development platform

Precision Mold 3D Design System

2. Intelligent Manufacturing Zone

Microfluidic chip fully automated production line

IVD in vitro diagnostic equipment, molecular diagnostic POCT, real-time fluorescence PCR, microfluidic biochemical analyzer, ultrasonic lysis instrument, etc

Dry biochemical analyzer for life science instruments, multi-functional detection instrument for animals, microbial sample pretreatment system, fully automatic sample cup system, etc

3. Mass production conversion area

Real time demonstration of automated assembly line

Big data-driven process optimization dashboard

About WONGENY

The company was established in Suzhou in 2018 and is the pioneer of fully automated microfluidic chip production lines worldwide. As a key state-owned capital investment enterprise in Suzhou, it has received multiple rounds of investment from state-owned capital and market-oriented funds. After years of research and development accumulation, we currently have OEM/ODM/CDMO service capabilities that integrate automation, chip consumables, and life science instruments, which can meet customers' multi-dimensional needs for research and development, manufacturing, and production. Our service areas cover in vitro diagnostics, medical devices, life sciences, biomedicine, etc. We specialize in the research and development, manufacturing, production process development, mold manufacturing, and mass production services of high-value biological consumables and life science instruments represented by microfluidic chips. We also provide customers with high-quality services in molecular testing, cell culture, immunotherapy, biopharmaceuticals, medical devices, and other areas.

Although Diagman 2025 has come to an end, the innovation pace of the in vitro diagnostic industry will never stop.WONGENY will continue to deepen its cultivation in the field of IVD, and provide better solutions to help achieve the strategic goal of "Healthy China 2030".Looking forward to working together with more industry partners to promote the high-quality development of the entire IVD industry chain!